|
|
 |
|
| News Release |
|
|
Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 1996 Release |
|
| December 19, 1996 | |
Eisai and Astra Settle Patent Dispute Regarding a Proton Pump Inhibitor
| |
| December 12, 1996 | |
Distribution of "ProHance Injection", Non-ionic MRI Diagnostic Agent, to Be Unified through Eisai
| |
| December 12, 1996 | |
Eisai Licenses Antifungal Triazole to Bristol-Myers Squibb
| |
| November 26, 1996 | |
Eisai Contracts for Land Use for the Establishment of a Pharmaceutical Production Site in Suzhou, China
| |
November 25, 1996
(EST) | |
Eisai Receives FDA Marketing Clearance for ARICEPT(TM) (donepezil hydrochloride), A New Treatment for Alzheimer's Disease - Improves Cognition and Patient Function; is Well Tolerated -
| |
| October 11, 1996 | |
Eisai Submits a Marketing Authorisation Application (MAA) for ARICEPT(TM)(donepezil hydrochloride) - A New Drug Studied in the Treatment of Alzheimer's Disease in the UK-
| |
| September 25, 1996 | |
Eisai Co., Ltd. Confirms Receipt of FDA Approvable Letter
| |
| July 4, 1996 | |
Eisai Starts Construction of 4th Production (Packaging) Facility at Kawashima Production Facilities
| |
| June 6, 1996 | |
Eisai Purchases Land for Production of Synthetic Vitamin E in the U.S.
| |
May 1, 1996
(EST) | |
Eisai Pharmatechnology, Inc. Breaks Ground on $40 Million Facility at Research Triangle Park
| |
| April 22, 1996 | |
Nippon Glaxo and Eisai End Joint Development and Marketing Agreement for SN-308
| |
| April 9, 1996 | |
Eisai Establishes Elmed Eisai Co., Ltd. Selling "Value Generics"
| |
March 29, 1996
(EST) | |
Eisai Submits NDA for ARICEPT(TM) (donepezil hydrochloride), A New Drug Studied in the Treatment of Alzheimer's Disease
| |
| March 26, 1996 | |
Eisai Announces Positive Results of U.S. Phase III Clinical Trials for Drug Studied in the Treatment of Alzheimer's Disease
| |
| March 1, 1996 | |
AHP and Eisai End their Joint Venture Partnership | |
| | | |
|
|
|
